Can you profit from Asaleo Care Ltd, Monash IVF Group and Spotless Group Holdings Ltd?

You might have missed the float, but you haven't missed the boat!

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The initial public offering (IPO) boom rolls on with a number of very large businesses recently listing on the ASX and plenty more on the way.

Some commentators are speculating that the market is starting to get a little weary of all the companies being offloaded by private equity with two proposed floats – Hirepool Group and Mount Adrah Gold – recently being withdrawn.

However for stocks which have listed so far there has been a pretty good success rate of immediate profits for investors. Take residential aged care facilities provider Japara Healthcare Ltd (ASX: JHC) for instance, which closed up over 25% on its first day of trade – nice gains for those lucky enough to get a stake in that IPO!

Not all floats have such a resounding first day success however, and this can create the opportunity for investors who didn't receive a float allocation to purchase on-market.

Three stocks which recently listed are Asaleo Care Ltd (ASX: AHY), Monash IVF Group Ltd (ASX: MVF) and Spotless Group Holdings Ltd (ASX: SPO).

Asaleo is a manufacturer of personal hygiene products including well-known brands such as Sorbent and Libra. The float price was set at $1.65 per share and currently investors can purchase the stock on market at the same price.

Monash IVF is the second IVF provider to list on the ASX. Like its peer Virtus Health Ltd (ASX: VRT) the stock is commanding a lofty multiple, however unlike Virtus' stellar IPO listing, which has seen the stock price rocket, Monash's shares are currently selling for one cent under their float issue price of $1.85.

Spotless is best known for providing staffing services at large events such as football games at the MCG. Having only been taken private a few years ago some investors were wary of the company's quick return to public life. As a result the IPO was ultimately priced at $1.60, representing the very bottom of the indicative price range. The stock has not traded below the issue price but at $1.69 investors who 'missed out' still have the opportunity to purchase at only a very small premium.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »